ArticleCancer science2025

Emergence of PALB2 Reversion Mutations as a Mechanism of Resistance to Niraparib in Breast Cancer: A Case Report.

Maako Kawamura et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.